Results 181 to 190 of about 94,767 (268)

Mortality Among People With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

JAMA Netw Open
Corrigan L, Heywood L, Stewart GR, O'Nions E, Shelford H, Stott J, John A.   +6 more
europepmc   +1 more source

Gastrin-releasing peptide, neuromedin B, and symptom severity in adult attention-deficit hyperactivity disorder. [PDF]

Rev Assoc Med Bras (1992)
Tozoğlu EÖ, Özkaya AL.
europepmc   +1 more source

Comparing ADHD symptom network structure in Chinese youth with ADHD: ADHD alone vs. ADHD with comorbidities

Journal of Psychiatric Research
Luo, J., Shao, W., Wu, Y., Huang, H., Xu, G., Qi, Y., Overton, P., Zheng, Y., He, F.   +8 more
openaire   +2 more sources

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

Molecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur, Joel Rodrigues Vitória, Manuel Saiselet, Ligia Craciun, Denis Larsimont, Anne Lefort, Frédérick Libert, Carine Maenhaut, Sabine Costagliola, Maxime Tarabichi, Mirian Romitti, Vincent Detours   +11 more
wiley   +1 more source

Regional Variation in ADHD Treatment and Diagnosis Among Children and Adolescents in Denmark. [PDF]

Basic Clin Pharmacol Toxicol
Sonne H, Pottegård A, Hansen ASK, Bech M, Kildegaard H.   +4 more
europepmc   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source

Multimodal Machine Learning Approaches to Detect Attention-Deficit/Hyperactivity Disorder (ADHD) Using Physiological and Behavioural Biomarkers: A Systematic Review. [PDF]

Healthcare (Basel)
Walle AD, Bargshady G.
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source